Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung

Hypertension

Volumn 62, Issue 3, 2013, Pages 608-613

  Buurma, Aletta J ^a   Penning, Marlies E ^a   Prins, Frans ^a   Schutte, Joke M ^b   Bruijn, Jan Anthonie ^a   Wilhelmus, Suzanne ^a   Rajakumar, Augustine ^c   Bloemenkamp, Kitty W M ^a   Karumanchi, S Ananth ^c   Baelde, Hans J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

endothelial cells; hypertension, pregnancy induced; placental circulation; preeclampsia; sFlt 1 protein, human

Indexed keywords

CHORIONIC GONADOTROPIN; FMS LIKE TYROSINE KINASE 1; MESSENGER RNA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; Y CHROMOSOME;

ENDOTHELIAL CELLS; HYPERTENSION, PREGNANCY-INDUCED; PLACENTAL CIRCULATION; PREECLAMPSIA; SFLT-1 PROTEIN, HUMAN;

ADULT; CHORIONIC GONADOTROPIN; CHROMOSOMES, HUMAN, Y; FEMALE; HUMANS; LUNG; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TROPHOBLASTS; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84883267600     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01505     Document Type: Article

References (21)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-644.
2. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683.
3. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649-658.
4. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95:884-891.
5. Bujold E, Romero R, Chaiworapongsa T, Kim YM, Kim GJ, Kim MR, Espinoza J, Gonçalves LF, Edwin S, Mazor M. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med. 2005;18:9-16.
6. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 1998;59:1540-1548.
7. Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds L, Jeyabalan A, Hubel CA, Stillman IE, Parikh SM, Karumanchi SA. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension. 2012;59:256-264.
8. Chua S, Wilkins T, Sargent I, Redman C. Trophoblast deportation in preeclamptic pregnancy. Br J Obstet Gynaecol. 1991;98:973-979.
9. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta. 2008;29 suppl A:S73-S77.
10. Schmorl G. Pathologisch-Anatomische Untersuchungen Über Puerperal-Eklampsie. Leipzig: Verlag FCW Vogel; 1893.
11. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:IX-XIV.
12. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, Meijer GA. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29:19-24.
13. Lau YF. Detection of Y-specific repeat sequences in normal and variant human chromosomes using in situ hybridization with biotinylated probes. Cytogenet Cell Genet. 1985;39:184-187.
14. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Caniggia I. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1085-R1093.
15. Johansen M, Redman CW, Wilkins T, Sargent IL. Trophoblast deportation in human pregnancy-its relevance for pre-eclampsia. Placenta. 1999;20:531-539.
16. Askelund KJ, Chamley LW. Trophoblast deportation part I: Review of the evidence demonstrating trophoblast shedding and deportation during human pregnancy. Placenta. 2011;32:716-723.
17. Reddy A, Suri S, Sargent IL, Redman CW, Muttukrishna S. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia. PLoS One. 2009;4:e4453.
18. Pritchard S, Wick HC, Slonim DK, Johnson KL, Bianchi DW. Comprehensive analysis of genes expressed by rare microchimeric fetal cells in the maternal mouse lung. Biol Reprod. 2012;87:42.
19. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996;93:705-708.
20. O'Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A, Anderson JR, Roberts IA, Fisk NM. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004;364:179-182.
21. Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004;292:75-80.